4 insiders at Elanco Animal Health Incorporated (ELAN) reported open-market stock purchases totaling $533,557 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from Herendeen Paul (director), who acquired 10,000 shares at $23.68 on August 07, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-08-07 | VanHimbergen Robert M | officer: EVP and CFO | 4,200 | $23.08 | $96,926 | SEC Form 4 |
| 2026-08-07 | Herendeen Paul | director | 10,000 | $23.68 | $236,850 | SEC Form 4 |
| 2026-05-15 | Modi Rajeev A. | officer: SEE REMARKS | 4,911 | $20.35 | $99,939 | SEC Form 4 |
| 2026-05-15 | Simmons Jeffrey N | director, officer: PRESIDENT, CEO AND DIRECTOR | 4,971 | $20.09 | $99,843 | SEC Form 4 |
Elanco Animal Health Incorporated is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. It carried a market capitalization of about $11.1B, with shares trading near $22.29.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.